257 related articles for article (PubMed ID: 2097894)
21. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
[TBL] [Abstract][Full Text] [Related]
22. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
23. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
Bahçeciler NN; Işik U; Barlan IB; Başaran MM
Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
[TBL] [Abstract][Full Text] [Related]
25. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
26. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between the prick test and specific IgE against allergens of house dust and Dermatophagoides sp].
Corominas Sánchez M; Torres Rodríguez JM; Barbera Salva G; Aixala Abello S; Mestre Playa M; Buendia Gracia E
Allergol Immunopathol (Madr); 1982; 10(4):269-76. PubMed ID: 7180792
[TBL] [Abstract][Full Text] [Related]
28. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.
Silvestri M; Spallarossa D; Battistini E; Sabatini F; Pecora S; Parmiani S; Rossi GA
J Investig Allergol Clin Immunol; 2002; 12(1):52-9. PubMed ID: 12109533
[TBL] [Abstract][Full Text] [Related]
29. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
Varney VA; Tabbah K; Mavroleon G; Frew AJ
Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
[TBL] [Abstract][Full Text] [Related]
32. Effects of immunotherapy on histamine release: a study in allergy to dermatophagoides and house dust.
Trento H; Oehling A; Ona J
Allergol Immunopathol (Madr); 1982; 10(4):295-300. PubMed ID: 6184978
[TBL] [Abstract][Full Text] [Related]
33. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
Guez S; Vatrinet C; Fadel R; André C
Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
[TBL] [Abstract][Full Text] [Related]
35. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
Cantani A; Ragno V; Monteleone MA; Lucenti P; Businco L
J Investig Allergol Clin Immunol; 1996; 6(4):270-6. PubMed ID: 8844506
[TBL] [Abstract][Full Text] [Related]
36. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
39. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
[TBL] [Abstract][Full Text] [Related]
40. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
